Pelthos Therapeutics Inc.

8-K Regulation FD disclosure May 28, 2026 8-K Changed accountants; Director or officer change May 21, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Regulation FD disclosure Apr 14, 2026 8-K Director or officer change; Regulation FD disclosure Apr 10, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jan 13, 2026 8-K Director or officer change; Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Other events Jan 2, 2026 8-K Director or officer change; Other events Dec 23, 2025 8-K Shareholder vote results Dec 17, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Nov 7, 2025 8-K Regulation FD disclosure Oct 14, 2025 8-K/A Completed an acquisition or disposition; Results of operations (earnings release) Sep 16, 2025 8-K Regulation FD disclosure Sep 3, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Other events Jul 2, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Regulation FD disclosure May 1, 2025 8-K Entered a material agreement; Unregistered sale of equity; Changed accountants; Shareholder vote results; Regulation FD disclosure; Other events Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation Mar 3, 2025 8-K Regulation FD disclosure Nov 21, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Modified rights of security holders; Director or officer change; Amended charter or bylaws Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Shareholder vote results; Other events Oct 24, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Other events Aug 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Jul 29, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 16, 2024 8-K Other events Apr 9, 2024 8-K Regulation FD disclosure Mar 21, 2024 8-K Director or officer change; Other events Mar 18, 2024 8-K Regulation FD disclosure Mar 13, 2024